Search

Your search keyword '"Hou, Ye"' showing total 266 results

Search Constraints

Start Over You searched for: Author "Hou, Ye" Remove constraint Author: "Hou, Ye"
266 results on '"Hou, Ye"'

Search Results

6. Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective

7. Subtype-specific 3D genome alteration in acute myeloid leukaemia

9. Research on sustainable design of sports centre based on algorithm verification

11. Electricity Theft Detection Based on Multi-head Attention Mechanism

16. DDEL-06. MICROGLIA REPAIR THE DISRUPTED BLOOD-BRAIN BARRIER FOLLOWING LOW-INTENSITY PULSED ULTRASOUND THROUGH P2RY12 SIGNALING

19. Understanding organisational response to institutional pressures in information security management : two Chinese case studies

23. FIGURE 4 from Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells

24. Figure S1 from Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells

25. FIGURE 1 from Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells

26. FIGURE 2 from Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells

27. FIGURE 3 from Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells

28. Data from Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells

29. 381 Repeated Opening of the Blood-Brain Barrier With the Skull-implantable SonoCloud-9 (SC9) Device: Phase 1 Trial of Nab-Paclitaxel and SC9 in Recurrent Glioblastoma

31. Preservation and utilisation of historic buildings in old district of Guangzhou from the perspective of space syntax

33. CTNI-37. REPEATED OPENING OF THE BLOOD-BRAIN BARRIER WITH THE SKULL-IMPLANTABLE SONOCLOUD-9 (SC9) DEVICE: PHASE 1 TRIAL OF NAB-PACLITAXEL AND SC9 IN RECURRENT GLIOBLASTOMA

36. How do competitors and partners shape corporate R&D investments.

37. Abstract 2953: Subtype-specific and structure variation induced 3D genome alteration in acute myeloid leukemia

38. Repeated opening of the blood-brain barrier with the skull-implantable SonoCloud-9 (SC9) device: Phase 1 trial of nab-paclitaxel and SC9 in recurrent glioblastoma.

40. Epigenomics analysis of miRNA cis-regulatory elements in pig muscle and fat tissues

41. Large-field skull-implantable ultrasound opens the blood-brain-barrier leading to ultrastructural and transcriptional alterations in endothelium and enhanced drug penetration to the human brain: phase 1 trial using albumin-bound paclitaxel in recurrent glioblastoma

49. Additional file 4 of Subtype-associated epigenomic landscape and 3D genome structure in bladder cancer

50. Additional file 16 of Subtype-associated epigenomic landscape and 3D genome structure in bladder cancer

Catalog

Books, media, physical & digital resources